Pan-Cancer Analysis of the Prognostic and Immunological Role of HSF1: A Potential Target for Survival and Immunotherapy

Figure 4

Association between the HSF1 expression and DSS in cancer patients. (a) A forest plot of hazard ratios of HSF1 in 33 types of tumors. (b) Kaplan-Meier survival curves of DSS for patients stratified by the different expressions of HSF1 in LIHC, KIRP, THCA, and UVM.

(a)

(b)